Pharmaceutical giant Merck to manufacture flagship cancer drug Lynparza at new €1 billion Irish facility, dealing significant blow to UK's life sciences sector and raising fresh post-Brexit trade concerns.
Major pharmaceutical giants AstraZeneca, MSD (Merck), and Eli Lilly announce massive new investments in UK research and manufacturing, signalling a major vote of confidence in the British life sciences sector following the US election result.
Pharmaceutical giant MSD, known as Merck in the US, is significantly expanding its UK presence with a new state-of-the-art research hub in London, generating over 125 new high-skilled jobs and reinforcing the city's status as a global life sciences leader
The UK government has secured 250,000 courses of Merck's molnupiravir, an innovative antiviral pill shown to halve hospitalisations in a major scientific breakthrough.